ReviewCancers2023

Treatment Strategy for Ultra-High-Risk Multiple Myelomas with Chromosomal Aberrations Considering Minimal Residual Disease Status and Bone Marrow Microenvironment.

Kazuhito Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.